J. Selmer

发表

Native immunoblotting: Transfer of membrane proteins in the presence of non‐ionic detergent

O. Bjerrum, J. Selmer, A. Lihme, 1987 .

TTP4000, a soluble fusion protein inhibitor of Receptor for Advanced Glycation End Products (RAGE) is an effective therapy in animal models of Alzheimer's disease

M. Kindy, A. Mjalli, Bin Zhou, 2013 .

Human ventricular myosin light chain isotype 1 as a marker of myocardial injury.

K. Thygesen, J. Ravkilde, P. Søgaard, 1994, Cardiology.

Monoclonal antibodies against human angiotensinogen, their characterization and use in an angiotensinogen enzyme linked immunosorbent assay.

M. Ballegaard, J. Selmer, I. Rubin, 1988, Journal of immunoassay.

Modulation of metabolism through transcriptional control has created new treatment opportunities for type 2 diabetes.

J. Fleckner, E. Boel, T. Albrektsen, 2000, Current pharmaceutical biotechnology.

HYPOTHALAMIC–PITUITARY–ADRENOCORTICAL FUNCTION IN CHRONIC ALCOHOLISM

H. Kehlet, H. Hasselbalch, L. Sestoft, 1982, Clinical endocrinology.

A Specific Immunologic Assay for Functional Plasminogen Activator Inhibitor 1 in Plasma – Standardized Measurements of the Inhibitor and Related Parameters in Patients with Venous Thromboembolic Disease

B. Lind, S. Thorsen, J. Selmer, 1992, Thrombosis and Haemostasis.

Immunochemical determination of acetylcholinesterase in amniotic fluid--an evaluation of eleven monoclonal antibodies.

B. No̸rgaard-Pedersen, J. Zeuthen, O. Bjerrum, 1987, Clinica chimica acta; international journal of clinical chemistry.

Ethanol metabolism and lipid synthesis by isolated liver cells from fed rats.

N. Grunnet, J. Selmer, 1976, Biochimica et biophysica acta.

Native and degraded fibronectin: new immunological methods for distinction.

I. Clemmensen, H. Eriksen, J. Selmer, 1984, Scandinavian journal of clinical and laboratory investigation.

Kinetics of inhibition of tissue-type and urokinase-type plasminogen activator by plasminogen-activator inhibitor type 1 and type 2.

S. Thorsen, I Lecander, B Astedt, 1988, European journal of biochemistry.

The role of fragment X polymers in the fibrin enhancement of tissue plasminogen activator-catalyzed plasmin formation.

M. Meldal, L. Petersen, A. Holm, 1990, The Journal of biological chemistry.

Plasma and urine fibronectin concentration in kidney-transplanted patients.

I. Clemmensen, L. Tranebjaerg, H. Eriksen, 1984, Scandinavian journal of clinical and laboratory investigation.

A novel, fixed‐dose calcipotriol and betamethasone dipropionate cream for the topical treatment of plaque psoriasis: Direct and indirect evidence from phase 3 trials discussed at the 30th EADV Congress 2021

A. Armstrong, M. Praestegaard, J. Galván, 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.

Squamous cell carcinoma and keratoacanthomas are biologically distinct and can be diagnosed by light microscopy: a review

T. Skov, D. Weedon, L. Spelman, 2016, Histopathology.

A serological study with monoclonal antibodies to an antigen common to a wide range of bacteria

F. Larsen, D. Sompolinsky, J. Selmer, 1985 .

Immunological Relationship Between the Fast-Acting Plasminogen Activator Inhibitors from Plasma, Blood Platelets and Endothelial Cells Demonstrated with a Monoclonal Antibody Against an Inhibitor from Placenta

J. Zeuthen, S. Thorsen, J. Selmer, 1986, Thrombosis and Haemostasis.

Diabetic late complications: will aldose reductase inhibitors or inhibitors of advanced glycosylation endproduct formation hold promise?

E. Boel, T. Jensen, J. Selmer, 1995, Journal of diabetes and its complications.

Isolation of human erythrocyte acetylcholinesterase using phase separation with Triton X-114 and monoclonal immunosorbent chromatography.

F. Larsen, O. Bjerrum, J. Selmer, 1985, Journal of applied biochemistry.

Plasminogen Activator Inhibitor-1 Is the Primary Inhibitor of Tissue-Type Plasminogen Activator in Pregnancy Plasma

J. Zeuthen, S. Thorsen, J. Selmer, 1987, Thrombosis and Haemostasis.

MC2-01 Cream Has Improved Overall Psoriasis Treatment Efficacy Compared to Calcipotriene Plus Betamethasone Dipropionate Topical Suspension

M. Præstegaard, J. Selmer, L. Gold, 2019 .

A Sensitive Solid-Phase Immunosorbent Assay for Tissue-Type Plasminogen Activator Activity in Plasma Using Trinitrobenzoylated Poly-D-Lysine as a Stimulator for Plasminogen Activation

J. Brender, S. Thorsen, P. Handest, 1987, Thrombosis and Haemostasis.

The role of RAGE in amyloid-beta peptide-mediated pathology in Alzheimer's disease.

R. Nelson, B. Sahagan, A. Schmidt, 2009, Current opinion in investigational drugs.

Biological background subtraction improves immunoscintigraphy by subsequent injection of antigen.

J. Selmer, N. Tromholt, 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Detection of deep venous thrombosis with indium 111-labelled monoclonal antibody against tissue plasminogen activator

B. Hesse, J. Selmer, N. T. Nielsen, 2005, European Journal of Nuclear Medicine.

Analytical evaluation of a sensitive enzyme immunoassay for determinations of creatine kinase isoenzyme MB.

M Hørder, M. Hørder, P. Jørgensen, 1990, Clinical chemistry.

Validation of the Self-Reported Psoriasis Treatment Convenience Scale (PTCS)

S. Feldman, M. Præstegaard, A. H. Andreasen, 2021, Dermatologic Therapy.

A Phase 3, Randomized Trial Demonstrating the Improved Efficacy and Patient Acceptability of Fixed Dose Calcipotriene and Betamethasone Dipropionate Cream.

M. Praestegaard, L. Stein Gold, J. Selmer, 2021, Journal of drugs in dermatology : JDD.

A Phase 3, Randomized Trial Demonstrating the Improved Efficacy and Patient Acceptability of Fixed Dose Calcipotriene and Betamethasone Dipropionate Cream

M. Praestegaard, L. Stein Gold, J. Selmer, 2022, Journal of Drugs in Dermatology.

A dose-finding trial with a novel ingenol derivative (ingenol disoxate: LEO 43204) for field treatment of actinic keratosis on full face or 250 cm2 on the chest

G. Goldenberg, L. Guenther, L. Stein Gold, 2017, The Journal of dermatological treatment.

A randomized, phase IIa exploratory trial to assess the safety and preliminary efficacy of LEO 43204 in patients with actinic keratosis

H. Soyer, T. Prow, J. Selmer, 2016, The British journal of dermatology.

Efficacy, quality of life, and treatment satisfaction: an indirect comparison of calcipotriol/betamethasone dipropionate cream versus foam for treatment of psoriasis

A. Bewley, A. Reich, J. Galván, 2022, Current Medical Research and Opinion.

A pooled analysis of randomized, controlled, phase 3 trials investigating the efficacy and safety of a novel, fixed dose calcipotriene and betamethasone dipropionate cream for the topical treatment of plaque psoriasis

M. Praestegaard, A. Pinter, J. Selmer, 2021, Journal of the European Academy of Dermatology and Venereology : JEADV.

EXPLOITATION OF ANTIBODIES IN THE STUDY OF CELL MEMBRANES

F. Larsen, O. Bjerrum, J. Selmer, 1985 .